STRATEC SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.5 EUR | -4.71% |
|
-4.16% | -8.89% |
| Apr. 29 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
| Apr. 26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
Presenter SpeechFederica Lussana (Analysts)Good morning, everyone. My name is Federica Lussana...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
41.5
EUR
Average target price
42.33
EUR
Spread / Average Target
+2.01%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.89% | 571M | |
| +8.07% | 219B | |
| +7.87% | 184B | |
| +12.75% | 138B | |
| -1.37% | 62.54B | |
| +4.88% | 52.22B | |
| +11.59% | 51.73B | |
| +2.71% | 41.4B | |
| +4.90% | 37.17B | |
| +23.75% | 31.76B |
- Stock Market
- Equities
- SBS Stock
- News Stratec SE
- Transcript : Stratec SE Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 11